The PDE4B gene confers sex-specific protection against schizophrenia.
BACKGROUND
Phosphodiesterase 4B (PDE4B) is a candidate gene for schizophrenia and affective disorders through its disruption by a chromosomal translocation in an individual with schizophrenia, its inhibition by the antidepressant rolipram, and its physical interaction with another key candidate, Disrupted in Schizophrenia (DISC1).


OBJECTIVE
To determine the contribution made by PDE4B to the population risk of schizophrenia and bipolar disorder by carrying out a case-control association study.


METHODS
Twenty-six tagging single nucleotide polymorphisms were selected across the PDE4B gene and genotyped in DNA samples from 386 schizophrenia cases, 368 bipolar disorder cases and 455 controls.


RESULTS
Single single nucleotide polymorphisms and a resulting haplotype conferred a protective effect against schizophrenia in the female population. The haplotype result remained significant after correction for multiple testing (P=0.012).


CONCLUSIONS
The observation that a PDE4B haplotype alters the genetic risk of schizophrenia in the Scottish population complements the known participation of this gene in biological processes associated with mental illness. Further studies are needed to replicate this finding and identify underlying sequence variants.
Pickard
Benjamin S
BS
Medical Genetics Section, School of Clinical and Molecular Medicine, Molecular Medicine Centre, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK. ben.pickard@ed.ac.uk
Thomson
Philippa A
PA
Christoforou
Andrea
A
Evans
Kathryn L
KL
Morris
Stewart W
SW
Porteous
David J
DJ
Blackwood
Douglas H R
DH
Muir
Walter J
WJ
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000235:genetics*; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4; D005260:Female; D005819:Genetic Markers; D005838:Genotype; D006801:Humans; D020641:Polymorphism, Single Nucleotide; D018570:Risk Assessment; D012559:Schizophrenia / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control*; D012606:Scotland / Q000453:epidemiology
D005819:Genetic Markers; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4; C517360:PDE4B protein, human